Literature DB >> 1350569

Progressive changes in CD45RB phenotype and lymphokine production by murine CD4+ T cells after alloantigen exposure.

M L Birkeland1, T Kraus, L Tardelli, E Puré.   

Abstract

Changes in CD45R expression correlate with changes in phenotype in mouse, rat and human T cells. It has been shown in mouse that CD45RB high T cells produce mostly interleukin-2 (IL-2) while CD45RB low T cells produce more IL-4 than IL-2 after mitogen stimulation in vitro. CD45RB expression also decreases when T cells are stimulated. In this study we compared responses of CD45RB high and low CD4+ T cells to alloantigens. Although a majority of unstimulated murine T cells from unimmunized mice are CD45RB high, we were able to isolate and purify sufficient numbers of T cells to study their response to alloantigens. When separated cells were stimulated in vitro with alloantigen the CD45RB high T cells became heterogeneous for their expression of CD45RB, indicating that high cells decrease their expression of CD45RB epitopes. Surprisingly, only CD45RB high T cells from unimmunized mice were alloreactive, as measured by proliferation and lymphokine secretion. In contrast, both CD45RB high and low populations from mice primed with allogeneic spleen were responsive to alloantigens. The 'primary' response of T cells from alloantigen-primed mice to third party stimulators is 10-fold greater in the CD45RB high population than in the CD45RB low, as would be predicted by our results in the primary mixed lymphocyte/leucocyte reaction (MLR). Furthermore, the response of CD45RB low T cells from unprimed mice and the response to third party alloantigen from primed mice was reconstituted by the addition of exogenous IL-2. The response of CD45RB low cells from primed mice was specific, as the third party alloresponsive cells were again primarily contained within the CD45RB high population. In the CD45RB high population in the secondary MLR we observed an increase in the production of IL-4 relative to IL-2.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1350569      PMCID: PMC1384842     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  34 in total

1.  Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event.

Authors:  H M Serra; J F Krowka; J A Ledbetter; L M Pilarski
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

2.  The functionally distinct subpopulations of human CD4+ helper/inducer T lymphocytes defined by anti-CD45R antibodies derive sequentially from a differentiation pathway that is regulated by activation-dependent post-thymic differentiation.

Authors:  L T Clement; N Yamashita; A M Martin
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

3.  Epitopes on CD45R [T200] molecules define differentiation antigens on murine B and T lymphocytes.

Authors:  M L Birkeland; J Metlay; V M Sanders; R Fernandez-Botran; E S Vitetta; R M Steinman; E Puré
Journal:  J Mol Cell Immunol       Date:  1988

4.  Memory CD4+ T cells in man form two distinct subpopulations, defined by their expression of isoforms of the leucocyte common antigen, CD45.

Authors:  D Mason; F Powrie
Journal:  Immunology       Date:  1990-08       Impact factor: 7.397

5.  Phorbol esters specifically inhibit induction of immunoglobulin secretion in a murine B cell leukemia.

Authors:  L G Simpson; P C Isakson
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

6.  Functional and ontogenetic analysis of murine CD45Rhi and CD45Rlo CD4+ T cells.

Authors:  W T Lee; X M Yin; E S Vitetta
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

7.  Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies.

Authors:  H M Cherwinski; J H Schumacher; K D Brown; T R Mosmann
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

8.  Antiimmunoglobulin-treated B cells respond to a B cell differentiation factor for IgG1.

Authors:  P C Isakson
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

9.  Mouse spleen lymphoblasts generated in vitro. Recovery in high yield and purity after floatation in dense bovine plasma albumin solutions.

Authors:  R M Steinman; B G Machtinger; J Fried; Z A Cohn
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

10.  T-independent and T-dependent steps in the murine B cell response to antiimmunoglobulin.

Authors:  M L Birkeland; L Simpson; P C Isakson; E Pure
Journal:  J Exp Med       Date:  1987-08-01       Impact factor: 14.307

View more
  6 in total

1.  Impairment of leukocyte trafficking in a murine pleuritis model by IL-4 and IL-10.

Authors:  Jay S Fine; Alberto Rojas-Triana; James V Jackson; Laura W Engstrom; Gregory S Deno; Daniel J Lundell; Loretta A Bober
Journal:  Inflammation       Date:  2003-08       Impact factor: 4.092

2.  Evolution of CD4 T-cell subsets following infection of naive and memory immune mice with Mycobacterium tuberculosis.

Authors:  J P Griffin; I M Orme
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

3.  Identical expression of CD45R isoforms by CD45RC+ 'revertant' memory and CD45RC+ naive CD4 T cells.

Authors:  M Hargreaves; E B Bell
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

4.  Tumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse model.

Authors:  C Schneider; T Schmidt; C Ziske; K Tiemann; K-M Lee; V Uhlinsky; P Behrens; T Sauerbruch; I G H Schmidt-Wolf; P F Mühlradt; J Schmidt; A Märten
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

5.  Blomia tropicalis-Specific TCR Transgenic Th2 Cells Induce Inducible BALT and Severe Asthma in Mice by an IL-4/IL-13-Dependent Mechanism.

Authors:  Yen Leong Chua; Ka Hang Liong; Chiung-Hui Huang; Hok Sum Wong; Qian Zhou; Say Siong Ler; Yafang Tang; Chin Pei Low; Hui Yu Koh; I-Chun Kuo; Yongliang Zhang; W S Fred Wong; Hong Yong Peh; Hwee Ying Lim; Moyar Qing Ge; Angela Haczku; Veronique Angeli; Paul A MacAry; Kaw Yan Chua; David M Kemeny
Journal:  J Immunol       Date:  2016-10-12       Impact factor: 5.422

6.  Molecular profiling of tumor-specific TH1 cells activated in vivo.

Authors:  Kristina Berg Lorvik; Ole Audun Werner Haabeth; Trevor Clancy; Bjarne Bogen; Alexandre Corthay
Journal:  Oncoimmunology       Date:  2013-05-01       Impact factor: 8.110

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.